| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC2146 |
| Trial ID | NCT04020575 |
| Disease | Sporadic Breast Cancer |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | huMNC2-CAR44|huMNC2-CAR22 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
| Year | 2020 |
| Country | United States |
| Company sponsor | Minerva Biotechnologies Corporation |
| Other ID(s) | 10038 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||